Compare BMRN & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | OC |
|---|---|---|
| Founded | 1996 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 9.3B |
| IPO Year | 1999 | N/A |
| Metric | BMRN | OC |
|---|---|---|
| Price | $53.40 | $113.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | $88.42 | ★ $157.33 |
| AVG Volume (30 Days) | ★ 3.0M | 2.0M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | N/A |
| Revenue | $3,094,001,000.00 | ★ $11,659,000,000.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $7.57 | N/A |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | 12.39 | ★ 21.69 |
| 52 Week Low | $50.76 | $97.53 |
| 52 Week High | $73.51 | $203.68 |
| Indicator | BMRN | OC |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 52.59 |
| Support Level | $53.03 | $97.53 |
| Resistance Level | $54.66 | $116.00 |
| Average True Range (ATR) | 1.45 | 3.75 |
| MACD | -0.11 | 2.16 |
| Stochastic Oscillator | 31.61 | 87.79 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.